Safety and efficacy of a docetaxel-5FU-oxaliplatin regimen with or without trastuzumab in neoadjuvant treatment of localized gastric or gastroesophageal junction cancer: A retrospective study

doi:10.4251/wjgo.v11.i8.634

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7118)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

432

WORD

305

HTML

2966

Figures (1-2)

319

Tables (1-4)

649

Sum=4671

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

871

Download

1576

Sum=2447

Aug 15, 2019 (publication date) through Feb 11, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Aug 15, 2019; 11(8): 634-641
Published online Aug 15, 2019. doi: 10.4251/wjgo.v11.i8.634

Table 4 Surgical and pathological results (n = 33)

Type of surgery
Subtotal gastrectomy	11 (33)
Total gastrectomy	11 (33)
Oesophagectomy	11 (33)
Resection Grade
R0	30 (90)
R1	3 (10)
Complete (TRG 1a)^†	12 (36)
Subtotal (TRG 1b)	8 (24)
Partial (TRG 2)	4 (13)
Minimal or none (TRG 3)	9 (27)
yN0	21 (63)
yN 1	6 (19)
yN2	6 (19)

Citation: Basso V, Orry D, Fraisse J, Vincent J, Hennequin A, Bengrine L, Ghiringhelli F. Safety and efficacy of a docetaxel-5FU-oxaliplatin regimen with or without trastuzumab in neoadjuvant treatment of localized gastric or gastroesophageal junction cancer: A retrospective study. World J Gastrointest Oncol 2019; 11(8): 634-641
URL: https://www.wjgnet.com/1948-5204/full/v11/i8/634.htm
DOI: https://dx.doi.org/10.4251/wjgo.v11.i8.634